Related Experiment Videos
Current issues in viral assays and viral clearance evaluation
1SmithKline Beecham Pharmaceuticals, King of Prussia PA, USA.
Summary
Detecting viral contaminants in biopharmaceuticals is challenging due to assay limitations. A combination of rigorous testing, process controls, and viral clearance methods is essential to prevent virus infection in patients.
Area of Science:
- Biopharmaceutical Manufacturing
- Virology
- Analytical Chemistry
Background:
- Viral contaminants pose significant risks in biopharmaceutical production due to limitations in current detection assays, including sensitivity and specificity.
- Biological amplification of viruses in cell substrates or recipients exacerbates the risk of infection.
- Existing analytical methods struggle with the accurate detection of viral contaminants compared to chemical ones.
Purpose of the Study:
- To review the challenges and strategies for preventing viral contamination in biopharmaceuticals.
- To highlight the importance of a multi-faceted approach combining assays, engineering controls, and process-based viral clearance.
- To discuss current issues and the scientific basis for standards in viral safety.
Main Methods:
- Characterization of cell banks using a broad spectrum of assays for adventitious and endogenous agents.
- Lot-specific testing for selected viruses of concern.
- Implementation of engineering and procedural controls to minimize contamination.
- Design of processes with unit operations for virus removal or inactivation and efficacy evaluation.
Main Results:
- A combination of preventive measures, including cell bank characterization, lot testing, and process controls, is necessary for viral safety.
- No single measure is sufficient; a flexible, product-specific combination of strategies is required.
- Current approaches have successfully prevented viral infections in populations treated with cell culture-derived biopharmaceuticals.
Conclusions:
- A comprehensive strategy integrating robust analytical testing, stringent facility controls, and validated viral clearance steps is crucial for ensuring the safety of cell culture-derived biopharmaceuticals.
- Continuous evaluation of assays, control systems, and the scientific basis for standards is necessary to address emerging challenges in viral safety.
- The successful track record demonstrates the efficacy of a combined approach in protecting public health.